{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:08:22Z","timestamp":1779300502068,"version":"3.51.4"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["09-2024-0006"],"award-info":[{"award-number":["09-2024-0006"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Little information is available regarding the factors that contribute to the occurrence of right innominate vein stenosis in patients with chemoports. Thus, the aims of this study were to evaluate the prevalence of chemoport-related right innominate vein stenosis (CR-RIVS) in patients with colorectal cancer and to identify factors associated with increased CR-RIVS risk. This retrospective study included patients with colorectal cancer (age,\u2009\u2265\u200919 years) who underwent their first chemoport insertion via the right internal jugular vein between August 2015 and August 2020. The prevalence of CR-RIVS was evaluated using follow-up contrast-enhanced chest computed tomography post-chemoport insertion. Risk factors were analyzed using Classification and Regression Tree, Kaplan-Meier survival, and Cox regression analyses. A subgroup analysis was also conducted among patients in palliative care to assess the impact of bevacizumab and cetuximab treatment on the prevalence of CR-RIVS. Among 1,442 patients with colorectal cancer (mean age, 62.1\u2009\u00b1\u200911.8 years; 850 males), the prevalence of CR-RIVS was 6.6%. The median time from chemoport insertion to CR-RIVS occurrence was 405 days (interquartile range, 256\u2013908 days). The Classification and Regression Tree analysis identified palliative settings as the key predictor of CR-RIVS. Age, palliative settings, and a time\u00d7palliative setting interaction were identified as statistically significant variables (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In the 728 palliative patients, bevacizumab treatment was significantly associated with a higher risk of CR-RIVS (hazard ratio\u2009=\u20091.51, 95% confidence interval: 1.25\u20131.82,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001), whereas cetuximab was not (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.85). The CR-RIVS-free probability was lower in patients receiving palliative chemotherapy than in those undergoing adjuvant chemotherapy (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001); it was also lower in the bevacizumab-treated patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) in the palliative setting subgroup analysis. In summary, the prevalence of CR-RIVS was 6.6% in patients with colorectal cancer. Bevacizumab use showed the strongest association with CR-RIVS occurrence in the palliative subgroup analysis.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0348521","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:32:17Z","timestamp":1779298337000},"page":"e0348521","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemoport-related right innominate vein stenosis in patients with colorectal cancer: A retrospective risk factor analysis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-8477","authenticated-orcid":true,"given":"Junghoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8394-8033","authenticated-orcid":true,"given":"Jeong Sub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-0724","authenticated-orcid":true,"given":"Choong Guen","family":"Chee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihoon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngjune","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-2362","authenticated-orcid":true,"given":"Eugene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"19","key":"pone.0348521.ref001","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long-term use of central venous catheters in cancer patients","volume":"21","author":"M Verso","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9","key":"pone.0348521.ref002","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2005.03.5600","article-title":"Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer","volume":"24","author":"AYY Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0348521.ref003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13244-019-0770-2","article-title":"Complications of central venous port systems: a pictorial review","volume":"10","author":"S Machat","year":"2019","journal-title":"Insights Imaging"},{"issue":"4","key":"pone.0348521.ref004","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00270-011-0271-2","article-title":"Venous access ports: indications, implantation technique, follow-up, and complications","volume":"35","author":"EM Walser","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"pone.0348521.ref005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00270-002-2628-z","article-title":"Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement","volume":"26","author":"CF Gonsalves","year":"2003","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"pone.0348521.ref006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jvscit.2021.06.004","article-title":"Left innominate vein stenosis treated with graft replacement with concomitant cardiac surgery","volume":"7","author":"K Takahashi","year":"2021","journal-title":"J Vasc Surg Cases Innov Tech"},{"issue":"2","key":"pone.0348521.ref007","article-title":"Central venous stenosis of left versus right arm: its prevalence and effects on image quality in CT of the neck","volume":"81","author":"EJ Yun","year":"2012","journal-title":"Eur J Radiol"},{"issue":"6","key":"pone.0348521.ref008","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3348\/jksr.2016.75.6.471","article-title":"Venous Reflux on Contrast-Enhanced Head and Neck Magnetic Resonance Angiography: Analysis of Causative Factors","volume":"75","author":"DJ Shin","year":"2016","journal-title":"J Korean Soc Radiol"},{"issue":"1","key":"pone.0348521.ref009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3348\/kjr.2023.0224","article-title":"Vertebral Venous Congestion That May Mimic Vertebral Metastasis on Contrast-Enhanced Chest Computed Tomography in Chemoport Inserted Patients","volume":"25","author":"JI Shin","year":"2024","journal-title":"Korean J Radiol"},{"key":"pone.0348521.ref010","volume-title":"Vascular and interventional radiology","author":"K Valji","year":"1999"},{"issue":"1","key":"pone.0348521.ref011","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/asheducation-2014.1.306","article-title":"Central venous catheter-related thrombosis","volume":"2014","author":"W Geerts","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"pone.0348521.ref012","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2010.04126.x","article-title":"Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies","volume":"9","author":"W Saber","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"15","key":"pone.0348521.ref013","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.ejca.2004.06.023","article-title":"Risk factors for catheter-related thrombosis in cancer patients","volume":"40","author":"MET Tesselaar","year":"2004","journal-title":"Eur J Cancer"},{"issue":"4","key":"pone.0348521.ref014","doi-asserted-by":"crossref","first-page":"460","DOI":"10.21147\/j.issn.1000-9604.2018.04.09","article-title":"Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experience","volume":"30","author":"JH Kim","year":"2018","journal-title":"Chin J Cancer Res"},{"issue":"5","key":"pone.0348521.ref015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/0100-3984.2020.0124","article-title":"Vanishing bone metastasis: pictorial essay","volume":"54","author":"EMN Fukamizu","year":"2021","journal-title":"Radiol Bras"},{"issue":"4","key":"pone.0348521.ref016","article-title":"Vertebral Venous Congestion Mimicking Sclerotic Metastasis in the Absence of Venous Obstruction","volume":"208","author":"KS Beck","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"pone.0348521.ref017","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"P Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"pone.0348521.ref018","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1467-842X.2001.tb00294.x","article-title":"How can I deal with missing data in my study?","volume":"25","author":"DA Bennett","year":"2001","journal-title":"Aust N Z J Public Health"},{"key":"pone.0348521.ref019","doi-asserted-by":"crossref","first-page":"1280666","DOI":"10.3389\/fneph.2023.1280666","article-title":"Central vein stenosis in hemodialysis vascular access: clinical manifestations and contemporary management strategies","volume":"3","author":"G Echefu","year":"2023","journal-title":"Front Nephrol"},{"issue":"7","key":"pone.0348521.ref020","first-page":"883","article-title":"Systematic review: malfunction of totally implantable venous access devices in cancer patients","volume":"19","author":"GA Goossens","year":"2011","journal-title":"Support Care Cancer"},{"issue":"3","key":"pone.0348521.ref021","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1590\/1806-9282.20220869","article-title":"Effect of contrast medium on early detection and analysis of mediastinal lymph nodes in computed tomography","volume":"69","author":"G Polat","year":"2023","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"1","key":"pone.0348521.ref022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41747-023-00345-w","article-title":"Strategies for calculating contrast media dose for chest CT","volume":"7","author":"MK Henning","year":"2023","journal-title":"Eur Radiol Exp"},{"issue":"2","key":"pone.0348521.ref023","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3174\/ajnr.A2301","article-title":"Suboptimal contrast opacification of dynamic head and neck MR angiography due to venous stasis and reflux: technical considerations for optimization","volume":"32","author":"DR Hingwala","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"pone.0348521.ref024","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2214\/AJR.15.15559","article-title":"Distinguishing Untreated Osteoblastic Metastases From Enostoses Using CT Attenuation Measurements","volume":"207","author":"A Ulano","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"pone.0348521.ref025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2214\/AJR.17.18638","article-title":"Accuracy of CT Attenuation Measurement for Differentiating Treated Osteoblastic Metastases From Enostoses","volume":"210","author":"SM Elangovan","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"16","key":"pone.0348521.ref026","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab","volume":"99","author":"FA Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"pone.0348521.ref027","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jvsv.2020.01.010","article-title":"Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy","volume":"8","author":"Y Chen","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"pone.0348521.ref028","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-015-0418-x","article-title":"Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma","volume":"14","author":"N Chen","year":"2015","journal-title":"Mol Cancer"},{"key":"pone.0348521.ref029","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006278","article-title":"Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta\u2010analysis of more than 20 000 patients","volume":"6","author":"M Totzeck","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"pone.0348521.ref030","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1200\/JCO.2010.32.3220","article-title":"Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies","volume":"29","author":"HI Hurwitz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"19","key":"pone.0348521.ref031","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.2008.656","article-title":"Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis","volume":"300","author":"SR Nalluri","year":"2008","journal-title":"JAMA"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:32:22Z","timestamp":1779298342000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348521"}},"subtitle":[],"editor":[{"given":"Robert Jeenchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0348521","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}